Market Trends of Nutrigenomics Industry
This section covers the major market trends shaping the Nutrigenomics Market according to our research experts:
Obesity Segment is Anticipated to Witness Growth Over the Forecast Period
The obesity segment is anticipated to witness growth over the analysis period, among the other applications. The influence of genes on weight and associated eating behaviors is a prominent field of research in nutrigenomics. Taking these genes into account while providing nutrition counseling can enhance weight loss by resulting in more intelligent food recommendations and more behavior change. Thus, with an increase in the obese population globally, the demand for nutrigenomics is increasing, which is expected to contribute to segment growth.
Metabolic syndrome (MetS) is associated with an increased risk of obesity, type 2 diabetes mellitus, and cardiovascular diseases. As per an article published in BMC in March 2021, the prevalence of metabolic syndrome globally ranges from 20 to 25% in the adult population and 0 to 19.2% in children, but it can reach almost 80% in type 2 diabetes patients. As MetS pose the potential risk of obesity, clinically advised nutrition intake is necessary for the target population. Hence, the high risk of the obese population is anticipated to drive the demand for nutrigenomics. As a result, driving the segment growth.
The development activities by the major players to develop and innovate products are key factors that are fueling segment growth. For instance, in September 2022, nutrigenomics and wellness firm Healeo Nutrition, known for reversing fatty liver through the client's genetic data, launched its DNA-Based Weight Loss and Management Program to tackle obesity and weight loss through genetics. Such product innovation and launches are expected to drive segment growth.
Therefore, owing to the aforementioned factors, the obesity segment is expected to witness growth over the forecast period.
North America is Expected to Witness Significant Growth Over the Forecast Period
The market studied is growing in North America, and it is anticipated to continue its stronghold during the forecast period. Factors driving the North American nutrigenomics market are the introduction and development of direct-to-consumer nutrigenomics kits and an increase in the intake of specialized foods and diets. Furthermore, rising obesity rates, an aging population, rising healthcare costs, and the presence of well-established healthcare infrastructure all contribute to this trend.
The United States holds the largest share among the other countries in the region. Factors such as the increasing obese population coupled with a rising number of chronic disease patients are expected to drive the market studied in the country. Adults aged 45 to 54 years had the highest prevalence of obesity (39.3%) in 2021, according to the September 2022 CDC update, and all states and territories had more than 20% of adults with obesity in the United States in the same year. This burden of obesity among the target population in the country requires clinically advised diet plans for weight loss. Nutrigenomics research is gaining popularity in the country as it provides better weight loss plans to the target population.
Additionally, government organizations in the country are taking initiatives to support nutrigenomics research. For instance, in March 2022, the AHA issued a policy statement on nutritional support policies and recommendations for expanding and improving programs with a broad focus on food security. The purpose of food security priorities is to prevent chronic diet-related illnesses such as cardiovascular disease, diabetes, obesity, and cancer. Such initiatives are likely to create opportunities for nutrigenomics research. Thereby, it is expected to fuel market growth in the region.
Therefore, owing to the aforementioned factors, North America is expected to dominate the market studied over the forecast period.
